From Name:
From Email:
To Name:
To Email:

Optional Message:


Lyftogt perineural injection therapy® as a primary treatment for plantar fasciitis: A randomized, controlled pilot with crossover

from Scholar: Pilot and Validation Studies

Plantar fasciitis is a common condition that interferes with patient function and activity level. This study compared usual care to Lyftogt perineural injection therapy® as a primary treatment for plantar fasciitis. Patients with foot pain associated with plantar fasciitis were recruited in to the study. They were randomized into the usual care protocol or treatment with Lyftogt perineural injection therapy®. Patients in the injection group were injected weekly for eight weeks. Five milliliters of 5% dextrose in water were injected perineural to the saphenous nerve at the adductor canal and the deep tibial nerve at the bifurcation of the gastrocnemius muscles of the affected side. Patients who completed the eight-week usual care protocol, crossed over into the injection therapy arm. Patient assessed Roles and Maudsley Scores on a 1–4 scale, physician assessed pain with palpation on a 1–4 scale, and MSKUS measured plantar fasciitis thickness were tracked. Complete information for nine control and nine intervention patients was compiled. MSKUS measured plantar fasciitis thickness was significantly reduced in the intervention group (P = 0.019). Physician assessed pain with palpation was also significantly reduced for the compiled intervention group (P = 0.006). more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063